Corner Therapeutics

Corner Therapeutics

MA - Watertown
Biotechnology1 H-1B visas (FY2023)

Focus: Dendritic cell hyperactivation (hDC) platform, inflammasomes

Corner Therapeutics is a life sciences company focused on Dendritic cell hyperactivation (hDC) platform, inflammasomes.

Open Jobs
0
Interview Prep Quick Facts
Portfolio: 2 approved products
H-1B (2023): 1 approval
Portfolio Health
Post-LOE2 (100%)
2 total products

Hiring Trend

Stable
0
Open Roles
+0
Added
-0
Filled/Removed

Based on last 4 crawl cycles

Visa Sponsorship

Sponsors Work Visas
H-1B Petitions (FY2023)
1
Approved
0
Denied
100%
Rate

Source: USCIS H-1B Employer Data Hub